ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,118,911 | -73.4% | 279,222 | -3.7% | 0.00% | -83.3% |
| Q2 2023 | $11,730,591 | 0.0% | 290,074 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $11,730,591 | -14.3% | 290,074 | -1.4% | 0.01% | -14.3% |
| Q4 2022 | $13,684,417 | -99.0% | 294,162 | +982.7% | 0.01% | +600.0% |
| Q3 2022 | $1,409,256,000 | +9.7% | 27,169 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,284,279,000 | -3.3% | 27,169 | +45.6% | 0.00% | 0.0% |
| Q1 2022 | $1,328,148,000 | +29.8% | 18,659 | +36.4% | 0.00% | – |
| Q4 2021 | $1,022,991,000 | +46.0% | 13,680 | +10.9% | 0.00% | – |
| Q3 2021 | $700,525,000 | +29.1% | 12,331 | 0.0% | 0.00% | – |
| Q2 2021 | $542,687,000 | -18.7% | 12,331 | -8.9% | 0.00% | – |
| Q1 2021 | $667,645,000 | +139.2% | 13,537 | +104.2% | 0.00% | – |
| Q4 2020 | $279,123,000 | -45.1% | 6,630 | -40.4% | 0.00% | – |
| Q3 2020 | $508,846,000 | -25.8% | 11,115 | -18.6% | 0.00% | – |
| Q2 2020 | $685,568,000 | -10.0% | 13,654 | -7.8% | 0.00% | -100.0% |
| Q1 2020 | $761,936,000 | -5.2% | 14,815 | +13.9% | 0.00% | – |
| Q4 2019 | $803,387,000 | +15.1% | 13,004 | +11.9% | 0.00% | – |
| Q3 2019 | $698,070,000 | -36.4% | 11,619 | -10.7% | 0.00% | -100.0% |
| Q2 2019 | $1,097,279,000 | -5.8% | 13,004 | +6.7% | 0.00% | 0.0% |
| Q1 2019 | $1,164,293,000 | +88.5% | 12,189 | +39.8% | 0.00% | 0.0% |
| Q4 2018 | $617,638,000 | -17.2% | 8,720 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $745,810,000 | -40.5% | 8,727 | -19.3% | 0.00% | 0.0% |
| Q2 2018 | $1,253,458,000 | +114.6% | 10,815 | +49.8% | 0.00% | – |
| Q1 2018 | $584,170,000 | +142.8% | 7,220 | +76.1% | 0.00% | – |
| Q4 2017 | $240,588,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |